HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

entacapone (Comtan)

structure given in first source
Also Known As:
Comtan; 2-cyano-N,N-diethyl-3-(3,4-dihydroxy-5-nitrophenyl)propenamide; Comtess; OR 611; OR-611; (E)-2-cyano-3-(3,4-dihydroxy-5-nitro-phenyl)-N,N-diethyl-prop-2-enamide
Networked: 307 relevant articles (35 outcomes, 74 trials/studies)

Relationship Network

Drug Context: Research Results

Experts

1. Müller, Thomas: 9 articles (01/2022 - 03/2006)
2. Poewe, Werner: 7 articles (01/2018 - 01/2004)
3. Rascol, Olivier: 7 articles (01/2018 - 09/2004)
4. Gordin, A: 7 articles (10/2004 - 05/2000)
5. Ferreira, Joaquim J: 6 articles (01/2018 - 01/2008)
6. Woitalla, Dirk: 5 articles (10/2022 - 03/2006)
7. Kuoppamäki, Mikko: 5 articles (01/2019 - 06/2008)
8. Leinonen, Mika: 5 articles (12/2015 - 05/2005)
9. Hauser, Robert A: 5 articles (07/2009 - 01/2004)
10. Bremen, Dirk: 5 articles (05/2007 - 01/2004)

Related Diseases

1. Parkinson Disease (Parkinson's Disease)
2. Dyskinesias (Dyskinesia)
3. Neoplasms (Cancer)
4. Schizophrenia (Dementia Praecox)
5. Hypokinesia (Bradykinesia)

Related Drugs and Biologics

1. Levodopa (L Dopa)
2. Carbidopa (Lodosyn)
3. Stalevo
4. Catechol O-Methyltransferase (Methyltransferase, Catechol)
5. levodopa drug combination carbidopa (Nakom)
6. Dopa Decarboxylase
7. rasagiline (Azilect)
8. ropinirole (Requip)
9. Tolcapone (Tasmar)
10. Therapeutic Uses

Related Therapies and Procedures

1. Activities of Daily Living (ADL)
2. Therapeutics
3. Drug Tapering
4. Stents
5. Drug Therapy (Chemotherapy)